Author

Mickael Bonnet

Centre National de la Recherche Scientifique

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Approach:statistical model· 1

Frequent Co-Authors

Aurélie Cabannes‐HamyiD· 1 shared Camille Gillet· 1 shared Guillaume P. AndrieuiD· 1 shared Ismail Ceylan· 1 shared Lucien CourtoisiD· 1 shared Ludovic LhermitteiD· 1 shared Mélanie Féroul· 1 shared Mélodie QueriiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Aurélie Cabannes‐HamyORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Harnessing ALDH1A2 vulnerability in T-cell acute lymphoblastic leukemia

Guillaume P. Andrieu, Lucien Courtois, Mickael Bonnet, Camille Gillet, Mélodie Queri, Mélanie Féroul, Ludovic Lhermitte, Patrick Villarèse, Aurélie Cabannes‐Hamy, Philippe H. Rousselot, Mileydis Perez, Ismail Ceylan, Salvatore Spicuglia, Vahid Asnafi

This study identifies ALDH1A2 as a therapeutic target in T-ALL, showing its essential role in leukemic cell survival and demonstrating potent anti-leukemic activity with Dimate inhibition.

bioRxiv · Mar 11, 2025 · PreprintCancer Biology